A Novel KRAS Antibody Highlights a Regulation Mechanism of Post-Translational Modifications of KRAS during Tumorigenesis

KRAS is a powerful oncogene responsible for the development of many cancers. Despite the great progress in understanding its function during the last decade, the study of KRAS expression, subcellular localization, and post-translational modifications remains technically challenging. Accordingly, man...

Descripción completa

Detalles Bibliográficos
Autores principales: Assi, Mohamad, Pirlot, Boris, Stroobant, Vincent, Thissen, Jean-Paul, Jacquemin, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504708/
https://www.ncbi.nlm.nih.gov/pubmed/32887255
http://dx.doi.org/10.3390/ijms21176361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504708/
https://www.ncbi.nlm.nih.gov/pubmed/32887255
http://dx.doi.org/10.3390/ijms21176361

Ejemplares similares